Transplant Immunology is a leading interdisciplinary journal published by Elsevier, dedicated to the advancing field of transplant science and immunology. With a strong reputation in the academic community, it currently holds a significant position in the Q3 quartile in both the Immunology and Allergy categories, as well as Q2 in Transplantation, reflecting its impact and relevance within these fields. Since its inception in 1993, the journal has explored a broad spectrum of topics, ranging from immunological mechanisms to clinical aspects of transplantation, serving as a vital resource for researchers, healthcare professionals, and students alike. Although it is not an open-access journal, it offers critical insights and innovative research findings that bridge theoretical knowledge and practical application, thereby enhancing our understanding of transplant immunology. As the field continues to evolve, Transplant Immunology remains committed to publishing high-quality studies that advance the dialogue between immunology and transplantation, fostering collaboration and discovery.

Annals of Transplantation is a renowned academic journal published by INT SCIENTIFIC INFORMATION, INC, dedicated to the field of transplantation medicine. With a strong historical presence since its inception in 1996, this journal continues to provide a vital platform for disseminating innovative research, clinical studies, and review articles that contribute significantly to the ever-evolving landscape of organ transplantation. Holding a respectable Q2 ranking in the field of transplantation and a Q3 ranking in broader medicine categories as of 2023, the journal stands out with an impactful repository of knowledge that caters to a diverse audience, including researchers, healthcare professionals, and students. While it currently does not operate under an open access model, the scholarly contributions within are crucial for advancing practices, policies, and outcomes in transplantation. Whether you are seeking to keep abreast of recent advances or looking to publish your own findings, Annals of Transplantation serves as an essential resource for fostering collaboration and innovation in medical science.

TRANSPLANTATION is a premier journal in the field of organ transplantation, published by Lippincott Williams & Wilkins, that has been a cornerstone of transplantation research since its inception in 1963. With an impressive impact factor cementing its status, this journal is categorized in the top quartile (Q1) of its field, currently ranking 6th out of 54 in the Scopus Medicine Transplantation category, placing it in the 89th percentile. The journal publishes original research, clinical studies, and reviews that significantly advance our understanding of transplantation science, ensuring that professionals, researchers, and students remain informed of the latest developments. Although it is not an open-access journal, it offers valuable insights that contribute to enhancing practice and improving outcomes in transplantation medicine, making it an essential resource for anyone involved in this dynamic and impactful discipline.

Progress in Transplantation is a leading journal published by SAGE Publications Inc, focusing on the dynamic field of transplantation medicine. With an ISSN of 1526-9248 and E-ISSN 2164-6708, this journal serves as a crucial platform for researchers and clinicians aiming to share cutting-edge findings and advancements in organ transplantation. Despite not being an Open Access journal, it provides a significant contribution to the academic community, evidenced by its placement in the Q3 category of Transplantation for 2023 and its ranking of #33 out of 54 in Scopus, showcasing a percentile standing of 39th. Progress in Transplantation has been dedicated to publishing high-quality research since its inception in 2000, and it continues to be a vital resource for those seeking to enrich their knowledge and foster innovation within the field of transplantation, fostering collaboration among practitioners, researchers, and students alike.

Seminars in Thoracic and Cardiovascular Surgery, published by Elsevier Inc, is a prestigious journal that focuses on advancing the fields of thoracic and cardiovascular surgery, cardiology, and pulmonary medicine. With a strong impact factor and an impressive reputation indicated by its 2023 rankings as Q2 in Cardiology and Cardiovascular Medicine, and Q1 in both Medicine (miscellaneous) and Surgery, the journal occupies a critical space in the academic landscape. Established in 1989, it has become a vital resource for researchers, clinicians, and students alike, fostering innovation through comprehensive reviews and cutting-edge studies. Although it does not offer open access, its robust editorial standards ensure that published articles contribute significantly to the ongoing discourse in surgical techniques and procedural advancements. Researchers and practitioners are encouraged to explore its rich compendium of peer-reviewed content that informs clinical practices and guides future investigations in the dynamic and evolving realm of thoracic and cardiovascular health.

The International Journal of Organ Transplantation Medicine, published by the Avicenna Organ Transplant Center, stands as a vital resource for the field of transplantation medicine. Established to advance scientific knowledge and clinical practices, this open access journal has been supporting the global research community since 2010, ensuring that groundbreaking findings are easily accessible to researchers, professionals, and students alike. With its ISSN of 2008-6490 and E-ISSN 2008-6482, the journal consistently showcases high-quality, peer-reviewed articles, addressing critical advancements in transplantation techniques, patient care, and immunology. Renowned for its commitment to excellence, it holds a Q3 ranking in transplantation for 2023 and ranks #32 out of 54 in the Scopus medicine transplantation category, placing it in the 41st percentile. Researchers are encouraged to submit their work, contributing to the journal's goal of improving outcomes in organ transplantation and fostering collaboration across disciplines.

Transplantation and Cellular Therapy is a leading journal published by Elsevier Science Inc, dedicated to advancing the fields of transplantation, immunology, cell biology, and molecular medicine. With its ISSN of 2666-6375 and E-ISSN 2666-6367, this journal serves as a vital resource for researchers, practitioners, and students aiming to stay at the forefront of innovative therapies and clinical practices in transplantation. As of 2023, it holds an impressive Q1 ranking in multiple categories, including Cell Biology, Hematology, Immunology and Allergy, Molecular Medicine, and Transplantation, reflecting its high impact and relevance in the scientific community. The journal, operating from its base in the Netherlands, supports Open Access publishing to enhance the dissemination and accessibility of groundbreaking research. Acknowledging the significance of transplantation and cellular therapies in modern medicine, Transplantation and Cellular Therapy is poised to propel future discoveries and developments in these critical domains.

TRANSPLANTATION PROCEEDINGS is a distinguished journal published by Elsevier Science Inc, focused on the field of transplantation and surgery. With a publication history spanning over five decades, from 1969 to 2024, this journal has consistently provided a platform for researchers and practitioners to share significant findings and advancements in organ transplantation and related surgical techniques. The journal is renowned for its rigorous peer-review process and has achieved a respectable impact factor within its categories, ranking in the Q3 quartile for both Surgery and Transplantation as of 2023. With Scopus rankings placing it in the 47th percentile in Medicine (Surgery) and the 43rd percentile in Medicine (Transplantation), TRANSPLANTATION PROCEEDINGS serves as a vital resource for academics and medical professionals seeking to stay updated on the latest empirical research, clinical practices, and innovative methodologies in the field. While it does not operate under an open-access model, the journal ensures that critical insights and data are accessible to its audience, enhancing the global discourse in transplantation science. For those dedicated to advancing transplant medicine, this journal represents an invaluable collection of knowledge and a forum for fostering innovative approaches to improve patient outcomes.

Pediatric Transplantation is a prestigious academic journal published by Wiley, focusing on the critical field of pediatric organ transplantation. Since its inception in 1997, the journal has played a pivotal role in disseminating groundbreaking research and clinical insights relevant to pediatric health, including both pediatrics and transplantation disciplines. With an impact factor that reflects its significance—ranking in the second quartile (Q2) within both Pediatrics, Perinatology and Child Health and Transplantation categories—it provides a vital platform for researchers and clinicians dedicated to improving outcomes for pediatric transplant patients. Pediatric Transplantation embraces a wide scope of studies, from basic science to clinical trials, promoting collaborations that enhance the well-being of young organ recipients. Published in the United Kingdom, this journal does not operate under an open access model, ensuring that the content is peer-reviewed and of the highest academic rigor. For professionals and scholars seeking to stay at the forefront of pediatric transplantation advancements, Pediatric Transplantation serves as an invaluable resource.

JOURNAL OF HEART AND LUNG TRANSPLANTATION, published by Elsevier Science Inc., serves as a premier platform for researchers and clinicians in the fields of Cardiology, Cardiovascular Medicine, Pulmonary and Respiratory Medicine, Surgery, and Transplantation. Since its inception in 1991, this esteemed journal has maintained a robust impact within the scientific community, currently holding a remarkable Q1 ranking in multiple categories as of 2023, indicative of its influential contributions to the field. With Scopus rankings placing it among the top ten in Surgery and fourth in Transplantation, it is essential reading for those looking to stay at the forefront of innovative transplantation techniques and cardiovascular research. Although not an open access journal, its rich content is crucial for advancing knowledge and promoting best practices, making it indispensable for professionals, students, and researchers dedicated to the life-saving field of heart and lung transplantation. The journal continues to foster academic excellence and facilitate impactful research, addressing contemporary challenges and innovations within these critical areas.